Theseus Pharmaceuticals Announces Closing of Tender Offer
Theseus Pharmaceuticals, Inc. today announced that Concentra Biosciences, LLC (“Concentra”) through its wholly owned subsidiary, Concentra Merger Sub II, Inc. (“Merger Sub”), has successfully completed the previously announced tender offer to acquire all outstanding shares of Theseus common stock for a price per share of (i) $4.05 in cash.
Theseus Pharmaceuticals Announces Closing of Tender Offer Read More »
